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Classification of pathogenic species according to the distinct host transcriptional responses that they elicit
may become a relevant tool for microarray-based diagnosis of infection. Individual strains of Mycobacterium
avium, an opportunistic pathogen in humans, have previously been shown to differ in terms of growth and
persistence. In order to cover a wide spectrum of virulence, we selected four M. avium isolates (2151SmO,
2151SmT, SE01, TMC724) that have distinct intramacrophage replication characteristics and cause differen-
tial activation in human macrophages. Following infection with each of these strains, the expression of 12,558
genes in human macrophages was systematically analyzed by microarray technology. Fifty genes (including
genes encoding proinflammatory cytokines, chemokines, signaling, and adhesion molecules) were differentially
expressed more than twofold in response to all of the M. avium isolates investigated and therefore constitute
a common macrophage signature in response to M. avium. The magnitude of regulation of most of these genes
was directly correlated with the host cell-activating capacity of the particular M. avium strain. The regulation
of a number of genes not previously associated with mycobacterial infections was apparent; these genes
included genes encoding lymphocyte antigen 64 and myosin X. In addition, individual response patterns typical
for some M. avium isolates could be defined by the pronounced upregulation of interleukin-12p40 (IL-12p40)
(in the case of 2151SmO) or the specific upregulation of SOCS-1 and IL-10 (in the case of SE01) in
macrophages. TMC724, a strain of avian origin, could not be classified by any one of these schemes, possibly
indicating the limits of pathogen categorization solely by immune response signatures.
The outcome of infection is the net consequence of the
immune defenses of the host and a pathogen’s capacity to
subvert them. Macrophages play a central role in regulating
innate and acquired immune responses against pathogens, but
several mycobacterial species have developed strategies to per-
sist in these cells even in the face of fully developed T-cell
immunity (reviewed in references 40 and 51). Mycobacterium
avium is an environmental microorganism and an opportunis-
tic pathogen in humans (33). M. avium causes lymphadenop-
athies in children, pneumonia in the context of predisposing
lung conditions, and disseminated infections in advanced-stage
AIDS patients (31, 34). M. avium has proven to be useful in
mouse models of infection to define key requirements in my-
cobacterial infections (3, 6, 8, 15, 21, 29).
Of particular interest when host-pathogen relationships at
the species level are compared, M. avium strains having differ-
ent origins or morphotypes have been shown to differ widely in
terms of replication and persistence, both in vitro and in vivo
in a mouse model of infection (5, 9, 15, 29, 43, 48, 52), although
the molecular basis for this variability in virulence remains
undetermined. Previous studies demonstrated an inverse cor-
relation between the virulence of some M. avium isolates and
their ability to induce tumor necrosis factor alpha (TNF-) in
murine macrophages, suggesting that virulent strains elicit only
very limited activation of macrophage effector mechanisms,
thereby escaping elimination (24, 49). Using primary human
monocyte-derived macrophages, we recently demonstrated that
intracellular growth control of some M. avium strains was crit-
ically dependent on the extent of mitogen-activated protein
(MAP) kinase phosphorylation, one essential signaling pathway
of macrophage activation (9). However, our studies also demon-
strated that there is no direct and simple correlation between
MAP kinase phosphorylation, TNF- secretion, and the capacity
of different M. avium strains to replicate inside macrophages.
The mechanisms underlying virulence and persistence may
therefore be more complex and may involve the coregulation
of specific signaling and transcriptional machinery in response
to each individual M. avium isolate. In the current study we
performed a systematic, comparative analysis addressing the
transcriptional response of macrophages after infection with
M. avium strains with different origins and virulence charac-
teristics. We carefully selected four strains which reflect a wide
repertoire of M. avium infectivity and persistence.
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M. avium 2151 was initially isolated from an AIDS patient in
the United States and was classified as a serovar 2 strain (7). Its
stably subcultivated morphotypes (smooth opaque [SmO] and
smooth transparent [SmT]) have become an intensively studied
and well-established model for colony morphotypes in M.
avium (5, 15, 20, 41). 2151SmO is known to strongly activate
macrophages of mouse and human origin and fails to multiply
intracellularly. SmT only weakly activates human and mouse
macrophages and shows progressive intracellular growth (9,
54). A second isolate from a European AIDS patient (SE01)
was included in the study because it represents a different, yet
common serovar (serovar 4), is virulent in mice, and has been
shown to readily replicate within human macrophages in the
face of massive host cell activation (9). The fourth strain,
TMC724 ( ATCC 25291), has been used by various labora-
tories to study macrophage activation and granuloma forma-
tion in the mouse model, in which it is the most virulent strain
known to date (5, 21, 29). In contrast to the clinical isolates of
M. avium, TMC724 was originally cultured from fowl. Since
nothing is known about the virulence of avian isolates in hu-
man macrophages, analysis of the gene expression pattern in-
duced by this strain afforded a unique opportunity to compare
evolutionarily distant prototypes of M. avium.
When they encounter microbes and microbial structures,
macrophages undergo complex functional reprogramming, as
recently shown by comprehensive gene expression analyses
(10, 14, 22, 42). Our study corroborates that there is an over-
lapping pattern of regulated genes in human macrophages
representing a general inflammatory response to all isolates of
M. avium. The quantity of differentially expressed genes and
the magnitude of gene regulation are directly correlated with
the overall macrophage-activating capacity of the individual M.
avium strain used for infection, as determined by MAP kinase
phosphorylation and TNF- production. Additionally, some
M. avium strains preferentially induce regulation of a private
set of genes that may strain specifically perturb the macro-
phage response to infection or that may counteract antimyco-
bacterial effector mechanisms. Importantly, however, one
strain (TMC724) could not be classified by gene response sig-
natures, most likely due to a lack of overall host cell activation.
MATERIALS AND METHODS
Bacteria. M. avium strain TMC724 (serovar 2), originally isolated from fowl,
causes a progressive infection with a high bacterial burden in all infected organs
and accelerated death of infected mice (21, 29). The two morphotypes of M.
avium strain 2151 (serovar 2), smooth transparent (SmT) and smooth opaque
(SmO), are subclones of an isolate obtained from an AIDS patient (7). While the
SmT morphotype causes a progressive infection in mice comparable to that
caused by strain TMC724, the SmO morphotype of strain 2151 is eradicated and
therefore classified as nonvirulent (4, 5, 9). M. avium strain SE01 (serovar 4),
initially cultivated from the blood of an AIDS patient, causes a chronic, nonpro-
gressive infection in the mouse model and can therefore be classified as inter-
mediately virulent (29). M. avium strains were passaged twice in C57BL/6 mice,
and the colony phenotype and serotype were confirmed. All strains were then
cultured in Middlebrook 7H9 medium (Difco, Detroit, Mich.) containing 10%
oleic acid-albumin-dextrose-catalase (Becton Dickinson, Heidelberg, Germany)
and 0.05% Tween 80 (Sigma, Deisenhofen, Germany) until the mid-log phase.
The absence of contaminating microorganisms was verified by plating culture
material on brain heart infusion agar (Difco) and Ziehl-Neelsen staining. The
suspension was frozen in aliquots at 70°C until use. For calculation of CFU,
aliquots were serially diluted in sterile, distilled water containing 0.05% Tween
80 and plated on 7H10 agar containing 0.075% pyruvate. After incubation for 3
weeks at 37°C CFU were determined. For infection bacterial aliquots were
thawed and centrifuged for 10 min at 835  g. Bacteria were resuspended in
phosphate-buffered saline and sonicated (3 to 5 min, 35 kHz; Bandelin, Berlin,
Germany) to disrupt aggregates. To rule out the presence of lipopolysaccharide
(LPS) in the assays, all strains were tested with a Limulus amebocyte lysate assay
(Biowhittaker, Walkersville, MD). The effective LPS concentration in the exper-
iments at inoculum ratios of 10:1 was below 2 pg/ml.
Isolation and cultivation of human monocyte-derived macrophages. Mononu-
clear cells were isolated from the peripheral blood of healthy volunteers by
density gradient centrifugation (11). Lymphocytes and monocytes were sepa-
rated by counterflow elutriation as previously described (27). Highly purified
(consistently 95%) monocytes were cultivated for 7 days in Teflon culture bags
(CellGenix, Freiburg, Germany) in RPMI 1640 (Biochrom, Berlin, Germany) in
the presence of 2% (vol/vol) heat-inactivated human AB serum, 2 ng/ml human
macrophage colony-stimulating factor (R&D Systems, Wiesbaden, Germany), 2
mmol/liter L-glutamine (Biochrom), 100 U/ml penicillin G (Biochrom), and 100
g/ml streptomycin (Biochrom). The viability of cells was always 95%, as
determined by trypan blue staining. Macrophages were phenotyped by deter-
mining the cell surface marker expression profile (CD14, macrophage mannose
receptor, carboxypeptidase M, HLA-DR) as described previously (46). Macro-
phages were cultivated in RPMI 1640 containing 10% (vol/vol) heat-inactivated
fetal calf serum (Biochrom) and 2 mmol/liter L-glutamine. Cultures were incu-
bated at 37°C in a humidified atmosphere containing 5% CO2.
Infection of human macrophages with M. avium: in vitro infection and MAP
kinase phosphorylation. A total of 0.4  106 human monocyte-derived macro-
phages (MDM) (at a concentration of 0.8  106 cells per ml) were inoculated
with 1.2  106 CFU of M. avium per well. A lower initial infection rate than the
infection rates used in all other experimental procedures was chosen to prevent
macrophage death during the 7-day culture, especially with highly replicative M.
avium isolates. After 4 h cells were washed vigorously with warm Hanks balanced
salt solution to remove extracellular bacteria. To determine bacterial uptake,
macrophages were lysed by addition of 0.1% saponin. Lysates were serially
diluted in sterile, distilled water containing 0.05% Tween 80 and plated on 7H10
agar containing 0.075% pyruvate. For investigation of bacterial growth, parallel
cultures were maintained for 3 and 7 days in 500 l medium (after 3 days 500 l
fresh medium was added to 7-day cultures). Subsequently, cells were washed,
lysed, diluted, and plated for CFU determination as described above. For anal-
ysis of MAP kinase phosphorylation, macrophages were incubated with M. avium
(4.0  106 CFU per well) for 30 min as described above. Cell lysates were
analyzed as described previously (46).
RNA isolation, reverse transcription PCR (RT-PCR), and ELISA. For mi-
croarray analyses 4.5  106 human macrophages were cultivated in tissue culture
plates (Nunc, Roskilde, Denmark) and infected with M. avium at a ratio of 10
mycobacteria per macrophage for 4 h. Culture supernatants of stimulated mac-
rophages were harvested and stored at20°C until analysis. A sandwich enzyme-
linked immunosorbent assay (ELISA) was used for detecting TNF- (H. Gallati,
Intex, Muttenz, Switzerland) (25). Assays were performed as recommended by
the manufacturer.
Macrophages were lysed by addition of TriFast FL (PeqLab, Erlangen, Ger-
many). Total RNA was isolated by phase separation with 1-bromo-3-chloropro-
pane (Sigma).
For validation of gene expression, equal amounts of RNA were reverse tran-
scribed (Superscript II RNase H reverse transcriptase; Invitrogen, Karlsruhe,
Germany) and used for quantitative RT-PCR (LightCycler technology; Roche)
using the following gene-specific primer pairs: for beta-2-microglobulin, forward
primer 5 GCTGTGCTCGCGCTACTCTC 3 and reverse primer (5 GCGGC
ATCTTCAAACCTCCAT 3); for TNF-, forward primer 5 GGCTCCAGGC
GGTGCTTGTTC 3 and reverse primer 5 AGACGGCGATGCGGCTGATG
3; for interleukin-12p40 (IL-12p40), forward primer 5 TCAGAGGGGACAA
CAAGGAGTATG 3 and reverse primer 5 CTGGGCCCGCACGCTAAT 3;
for lymphocyte antigen 64 (LY64) (CD180), forward primer 5 AGCTGCTTC
TTTTGGGTGGTG 3 and reverse primer 5 TTGGGGAACTTAATGGAGG
AAATA 3; and for myosin X, forward primer 5 CACGCTGCCATCCCACC
TCTC 3 and reverse primer 5 CCGCGCTGACACCCAACCA 3. For RT-
PCR of RANTES and pentraxin 3 (PTX3) the primer pairs described previously
were used (36, 44). Gene expression was expressed as the relative expression
normalized to beta-2-microglobulin expression. The specificity of amplified prod-
ucts was confirmed by sequence analyses.
DNA microarray hybridization and analysis. The quality and integrity of total
RNA isolated from human macrophages were controlled by analyzing all sam-
ples with an Agilent Technologies 2100 Bioanalyzer (Agilent Technologies,
Waldbronn, Germany). Equal amounts of total RNA of five individual donors
were pooled to perform biotin-labeled target synthesis for array hybridization.
The entire experimental approach was repeated with a second donor pool that
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was comparable in terms of the distribution of the ages, genders, and purified
protein derivative reactivities of the individuals.
For biotin-labeled target synthesis starting from total RNA, reactions were
performed using standard protocols supplied by the manufacturer (Affymetrix,
Santa Clara, CA). Briefly, 8 g total RNA (equal amounts from five different
donors per hybridization) were converted to double-stranded DNA using 100
pmol of a T7T23V primer (Eurogentec, Seraing, Belgium) containing a T7
promoter. The double-stranded DNA was then used directly in an in vitro
transcription reaction in the presence of biotinylated nucleotides using a T7
RNA polymerase (BioArray high-yield RNA transcript labeling kit; ENZO, New
York, NY). The concentration of biotin-labeled cRNA was determined by UV
absorbance. In all cases, 12.5 g of each biotinylated cRNA preparation was
fragmented and placed in a hybridization cocktail containing four biotinylated
hybridization controls (BioB, BioC, BioD, and Cre) as recommended by the
manufacturer. Samples were hybridized to an identical lot of Affymetrix U95Av2
human genome GeneChips for 16 h. Each U95Av2 GeneChip contains oligonu-
cleotides for 12,558 human genes and expressed sequence tags derived from
common UniGene clusters. After hybridization the GeneChips were washed,
stained with streptavidin-phycoerythrin, and read using an Affymetrix GeneChip
fluidic station and scanner.
Fluorescence intensities were normalized to median array intensities for all
conditions tested, and the fold changes were calculated relative to unstimulated
baseline controls. Analysis of data was done with gene expression software
(GeneChip, MicroDB, and Data Mining Tool; all obtained from Affymetrix) with
a filter for regulated genes that employed the following stringent criteria to
define genes as significantly differentially expressed: (i) a signal log2 ratio of 1
or 	1, signifying changes in the expression level between control conditions
(baseline) and stimulated cells; and (ii) a change in the P value of 	0.001 or
0.999, describing the likelihood and direction of change of expression for each
transcript. P values indicated the level of significance of the difference between
the baseline and experimental conditions based on the Wilcoxon signed-rank
test. Genes defined as differentially expressed were significantly regulated in both
donor pools, each of which consisted of five individual donors. Unless indicated
otherwise specifically below, genes represented by more than one transcript on
the Affymetrix U95Av2 GeneChip were considered a single gene for the discus-
sion of absolute numbers of differentially expressed individual genes.
Statistical analysis. For comparison of RT-PCR results, the global hypothesis
was tested according to Friedman. For posttesting, data obtained from indepen-
dent experiments were compared using the Wilcoxon rank test. The -error was
corrected by the Shaffer procedure.
RESULTS
Intramacrophage replication characteristics of M. avium
strains used in this study. Four different M. avium isolates
(TMC724, 2151SmT, 2151SmO, and SE01) that have previ-
ously been well characterized in terms of growth and persis-
tence in vitro and in vivo were used in this study (4, 5, 9, 29).
Determination of the viable CFU inside macrophages over a
7-day period postinfection revealed that 2151SmO was slowly
eliminated, that TMC724 persisted at inoculum levels, and that
2151SmT and SE01 replicated extensively over time (Fig. 1).
Overall, these characteristics of replication and persistence are
in good accordance with results from murine infection models,
with the notable exception of TMC724, which failed to show
the supreme virulence exhibited in mice in vivo (21, 29). Nev-
ertheless, with one strain nearly eradicated, one persisting, and
two highly replicating, a wide spectrum of virulence was rep-
resented even in this small sample of M. avium strains.
TNF- release and MAP kinase activation of macrophages
infected with different strains ofM. avium. The virulence of M.
avium strains has previously been correlated to their capacity
to induce cytokine release from infected macrophages (5, 24).
We compared the TNF- production of human monocyte-
derived macrophages after infection (10 bacteria per macro-
phage) with four selected M. avium strains (Fig. 2A). TMC724
and 2151SmT induced only small amounts of TNF-, and
consistently higher TNF- levels were induced by 2151SmT
than by TMC724 when an identical multiplicity of infection
(MOI) was used for stimulation. In contrast, 2151SmO and
SE01 induced the release of large amounts of TNF-, and
SE01 reproducibly triggered the highest levels of TNF-.
FIG. 1. Uptake and intracellular replication of four M. avium
strains in human macrophages. Human MDM were infected with the
smooth transparent (SmT) and smooth opaque (SmO) morphotypes of
M. avium strain 2151, strain TMC724, and strain SE01 at an MOI of 3.
CFU counts in lysed macrophages were determined 4 h and 3 and 7
days after infection. The values are means 
 standard deviations for
duplicates of one representative experiment of the experiments per-
formed.
FIG. 2. TNF- release and p38 MAP kinase activation in cultures
of human macrophages infected with different M. avium strains. (A)
Human MDM were infected with M. avium strains TMC724, 2151SmT,
2151SmO, and SE01 at an MOI of 10. Supernatants were harvested
after 4 h. Cytokine concentrations were measured by ELISA. The values
are means
 standard deviations for three independent experiments. ctrl.,
control. (B) Human MDM were incubated with M. avium strains
TMC724, 2151SmT, 2151SmO, and SE01 at an MOI of 10 for 30 min.
Cells were lysed, and aliquots of cell lysates were separated by sodium
dodecyl sulfate-polyacrylamide gel electrophoresis and immunoblotted
onto nitrocellulose membranes. The membranes were incubated with
specific anti-phospho-p38 antibodies, followed by a peroxidase-cou-
pled secondary antibody. Visualization was performed by enhanced
chemiluminescence. To control equal protein loading, the amounts of
total p38 were detected in the same lysates. The results of one repre-
sentative experiment of three independent experiments are shown.
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It appeared that it is possible that the differential capacity of
macrophages to secrete TNF- in response to different M.
avium strains might be determined by the differential intensity
of pretranscriptional signaling events. We therefore analyzed
MAP kinase activation in human macrophages induced by the
four M. avium strains after 30 min of stimulation. TMC724 and
2151SmT induced only weak phosphorylation of p38 and
ERK1/2 in human macrophages (Fig. 2B and data not shown).
However, the signal obtained for 2151SmT was usually stron-
ger than that obtained for TMC724 when a similar MOI (10
bacteria per macrophage) was used for stimulation. In con-
trast, 2151SmO and SE01 induced marked MAP kinase phos-
phorylation, and the signal induced by SE01 was consistently
stronger than that induced by 2151SmO (Fig. 2B).
These data indicate that the virulence, as measured by the
capacity to replicate within macrophages (Fig. 1), of individual
M. avium strains is not consistently associated with the absence
of strong macrophage activation. Conversely, the lowest levels
of TNF- induction or MAP kinase phosphorylation need not
necessarily correlate with a pronounced capacity of a given
strain to multiply. Overall, the quantity of macrophage re-
sponses, such as the level of TNF- secretion, after stimulation
with individual M. avium isolates is governed by the magnitude
of signal events, such as MAP kinase activation, occurring very
early after infection.
Gene expression profiles of human macrophages induced by
different strains of M. avium. In order to investigate whether
the macrophage response after infection with individual myco-
bacterial isolates might also differ qualitatively (i.e., in terms of
the kind of transcriptional response), we applied a systematic
approach using microarray analyses. Macrophages of different
donors were infected with each of the four M. avium strains at
a ratio of 10 bacteria per macrophage. Total RNA was isolated
4 h postinfection. We and other workers have previously noted
the donor-dependent variability of macrophage responses to
M. avium (9, 28). To minimize donor-dependent confounding
effects, equal amounts of total RNA obtained from cells of five
individual donors were pooled to perform biotin-labeled target
synthesis for array hybridization. The entire experimental ap-
proach was repeated with a second donor pool comparable in
terms of the distribution of the ages, genders, and purified
protein derivative reactivities of the individuals. Only genes
that were differentially expressed compared to unstimulated
control macrophages with a change in the expression level of at
least twofold (induced or repressed) in both donor pools were
considered for further in-depth analysis and are included in the
tables if the statistical criteria described in Materials and
Methods were met.
TMC724 induced differential expression of 57 genes (51
genes induced, 6 genes repressed) compared to uninfected
macrophages (Fig. 3). 2151SmT induced regulation of 113
macrophage genes (95 genes induced, 18 genes repressed),
whereas 175 genes (123 genes induced, 52 genes repressed)
were regulated in response to 2151SmO. SE01 induced differ-
ential expression of 224 genes (145 genes induced, 79 genes
repressed) (Fig. 3). Thus, the numbers of differentially ex-
pressed genes in response to these different M. avium isolates
reflect the individual capacity of each strain to activate mac-
rophages, as measured by MAP kinase phosphorylation or
TNF- release (Fig. 2 and 3).
When the infection-induced macrophage transcriptomes
were compared, the gene expression patterns in response to
the M. avium strains were found to overlap. Fifty different
genes (47 genes induced, 3 genes repressed) were identified as
differentially expressed in response to all strains (Table 1). At
this early time (4 h after infection) more than one-third of
these differentially expressed genes are involved in a proin-
flammatory macrophage response, and the molecules involved
include cytokines (IL-1, IL-6, TNF-, lymphotoxin ), che-
mokines (RANTES, IL-8, monocyte chemoattractant protein
1, macrophage inflammatory protein 1 [MIP-1], MIP-1,
MIP-2, MIP-2, MIP-3, etc.), cytokine and chemokine re-
ceptors (IL-7 receptor, CCR2, CXCR4), and adhesion mole-
cules (ICAM-1) (Table 1). The changes in the expression levels
of genes in these functional categories were more pronounced
than the changes in the expression levels of genes having a
different functional background. Additionally, a number of
genes whose products are involved in signaling cascades, tran-
scriptional events, the cell cycle, and antiapoptosis, as well as
genes encoding metabolic enzymes, were differentially ex-
pressed in response to infection with all M. avium strains (Ta-
ble 1). In general, for the majority of genes, the magnitude of
regulation in response to the individual M. avium strains could
be directly correlated with the TNF--inducing capacity of
each isolate (Fig. 2).
To independently confirm the microarray results for gene
induction by M. avium, three genes induced by all M. avium
strains were selected from different categories, and their ex-
pression was analyzed by quantitative PCR using the same
RNA samples with which microarrays had been hybridized.
Figure 4 shows that the expression levels of the cytokine
TNF- (Fig. 4A), the chemokine RANTES (Fig. 4B), and the
ancestral pattern recognition receptor PTX3 (Fig. 4C) induced
by each strain indeed were the same order of magnitude as the
expression levels observed in the microarray analyses (Fig. 4
and Table 1).
Search for a “virulence response signature”: M. avium
strain-specific gene expression profiles of human macro-
FIG. 3. Numbers of differentially expressed genes in human mac-
rophages after infection with four M. avium strains. Human macro-
phages were infected with M. avium strains TMC724, 2151SmT,
2151SmO, and SE01 (MOI, 10) for 4 h. Differential gene expression
was compared to expression in uninfected control cells using microar-
ray technology. An array analysis was performed with two independent
donor pools, each comprising five individuals. The total number of
differentially expressed genes (induction or suppression) found in both
donor pools is indicated.
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TABLE 1. Shared pattern of differentially expressed macrophage genes in response to M. avium strains TMC724,
2151SmT, 2151SmO, and SE01
Category Gene name (UniGene) Designation
Fold regulation ina
TMC724 2151SmT 2151SmO SE01
Cytokines Interleukin 1, beta IL-1b 7.41 15.51 19.87 16.02
Interleukin 6 (interferon, beta 2) IL-6 68.83 264.55 489.99 306.51
Tumor necrosis factor TNF 4.58 3.76 3.89 10.02
TNF superfamily, member 2 9.08 10.07 13.32 17.24
Lymphotoxin alpha TNF superfamily member 1 LTA 4.58 3.76 3.89 10.02
Chemokines Interleukin 8 IL-8 2.91 4.21 4.50 4.07
Small inducible cytokine A5 RANTES 4.36 19.02 21.86 20.20
GRO1 oncogene MGSA 36.55 63.10 81.27 75.78
GRO2 oncogene MIP-2A 11.32 15.57 19.93 18.96
GRO3 oncogene MIP-2B 11.61 15.00 17.36 21.64
Small inducible cytokine A2 MCP-1 2.55 4.21 5.09 3.69
Monocyte chemotactic protein 1 2.85 4.53 5.12 3.98
Small inducible cytokine A3 MIP-1A 3.08 4.19 4.71 4.76
Small inducible cytokine A4 MIP-1B 8.16 11.10 12.31 11.63
Small inducible cytokine subfamily A (Cys-Cys),
member 20
MIP-3A 24.43 70.86 114.24 132.60
Receptors Adenosine A2a receptor ADORA2A 12.37 9.44 12.80 13.95
Interleukin 7 receptor IL-7R 3.20 4.09 5.37 5.29
Tumor necrosis factor receptor superfamily,
member 4
TNFRSF4 2.81 4.58 5.01 5.58
Chemokine (C-C motif) receptor 2 CCR2 5.01 6.84 6.56 16.20
Chemokine (C-X-C motif), receptor 4 (fusin) CXCR4 3.94 4.35 4.79 11.98
Signal transduction Nef-associated factor 1 NAF1 2.41 2.50 3.02 2.72
TNF receptor-associated factor 1 TRAF1 4.83 6.86 8.15 8.40
Jagged 1 (Alagille syndrome) JAG1 3.59 4.51 5.03 6.76
Phosphodiesterase 4B, cAMP specific PDE4B 2.96 4.29 4.32 3.40
Thyroid hormone receptor interactor 10 TRIP10 2.96 4.06 5.60 7.17
Seven in absentia (Drosophila) homolog 2 SIAH2 2.41 2.88 2.66 3.95
Cytoskeleton Singed (Drosophila)-like (sea urchin fascin
homolog-like)
SNL 3.65 8.06 11.90 12.74
Transcription Nuclear factor of kappa light polypeptide LYT-10 2.19 2.48 3.02 3.44
Gene enhancer in B-cells 2 (p49/p100) LOC125387 3.46 2.91 4.83 5.03
Butyrate response factor 2 (EGF-resp. factor 2) BRF2 2.41 4.23 6.44 8.55
Enzymes Adenosine deaminase ADA 2.31 3.76 5.78 6.12
Prostaglandin-endoperoxide synthase 2 PTGS2 27.29 27.68 54.59 153.21
GTP cyclohydrolase 1 (dopa-responsive
dystonia)
GCH1 4.32 7.68 10.21 9.51
Carbohydrate (chondroitin 6/keratan) C6ST 2.46 2.52 3.02 3.28
Sulfotransferase 2
Antiapoptosis Tumor necrosis factor, alpha-induced protein 3 TNFAIP3 3.06 3.20 3.65 4.09
Immediate early response 3 IER3 3.38 3.98 4.34 4.66
Adhesion Intercellular adhesion molecule 1 (CD54),
human rhinovirus receptor
ICAM1 2.99 3.64 4.06 4.25
Tumor necrosis factor, alpha-induced protein 6 TNFAIP6 5.62 11.80 16.53 17.93
Proliferation/
cell cycle
Tumor necrosis factor receptor superfamily,
member 9
TNFRSF9 2.87 3.79 4.42 3.48
Tumor necrosis factor (ligand) superfamily,
member 9
TNFSF9 13.92 13.84 27.99 97.96
Putative lymphocyte G0/G1 switch gene GOS2 3.07 3.04 3.20 3.95
Pim-2 oncogene PIM2 2.62 3.55 4.44 4.51
Clotting Glycoprotein 1b (platelet), alpha polypeptide GP1B 3.06 4.00 3.67 3.99
Miscellaneous Tumor necrosis factor alpha-induced protein 2 TNFAIP2 3.68 5.02 5.90 6.61
Tumor suppressing subtransferable candidate 3 TSSC3 2.29 3.11 4.22 4.59
Myristoylated alanine-rich protein kinase C
substrate (MARCKS, 80K-L)
MACS 2.39 2.87 2.91 3.24
Continued on following page
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phages. All events examined thus far (MAP kinase phosphor-
ylation, TNF- secretion, quantity of genes regulated) pointed
to a macrophage-activating capacity that was intrinsic to each
M. avium strain but partially disparate from its virulence prop-
erties. We therefore sought to determine whether there are
any transcriptional signatures that allow categorization of iso-
lates according to their intracellular replicating characteristics.
The two morphotypes of M. avium strain 2151 have a com-
mon genotype, yet they differ profoundly in intracellular
growth. Therefore, they provided an excellent starting point to
study the macrophage responses to virulent and nonvirulent M.
avium isolates in a comparison of the host cell gene expression
profiles induced by them. In addition to the general macro-
phage response signature for infection with M. avium as de-
scribed above, direct comparison indeed identified genes that
were individually regulated following infection with these two
morphotypes (Table 2). The individual responses to 2151SmT
and 2151SmO covered 9% (10 genes; 5 genes induced and 5
genes repressed) and 39% (68 genes; 31 genes induced and 37
genes repressed), respectively, of all genes differentially ex-
pressed after infection with the individual morphotypes (Table
2).
In contrast to the overall amount of differentially expressed
genes that are induced by all four M. avium strains, the indi-
vidual response patterns show equal numbers of induced and
suppressed genes for 2151SmT and 2151SmO. While the ma-
jority of genes were regulated only between two- and fourfold
(close to the cutoff for twofold regulation), three genes were
found to be regulated more than 20-fold, the genes encoding
IL-12p40 (47-fold induction) and LY64 (23-fold repression) in
response to 2151SmO and the gene encoding myosin X (20-
fold induction) after infection with 2151SmT (Table 2).
IL-12 is well known to be a critical factor in controlling
mycobacterial infections (reviewed in references 13, 19, and
53). In contrast, there have been no reports on the role of
either LY64 or myosin X for modulating mycobacterial
growth. To independently confirm the differential expression
of the genes encoding these three molecules, human macro-
phages of five individuals were infected with M. avium
2151SmT or 2151SmO for 4 h, and total RNA was isolated and
used for quantitative RT-PCR.
2151SmO significantly induced expression of IL-12p40
mRNA in macrophages of all five donors compared to un-
stimulated control cultures (Fig. 5A). The closely related SmT
morphotype of strain 2151 also induced IL-12p40 mRNA
expression in four of five donors (Fig. 5A), albeit to a sig-
FIG. 4. Expression of TNF-, RANTES, and PTX3 mRNA in hu-
man monocyte-derived macrophages after infection with M. avium. Hu-
man MDM were incubated with M. avium isolates TMC724, 2151SmT,
2151SmO, and SE01 (MOI, 10) for 4 h. Total RNA was isolated, reverse
transcribed, and used for quantitative RT-PCR of TNF- (A), RANTES
(B), and PTX3 (C) mRNA normalized to beta-2-microglobulin mRNA
levels. The values indicate the fold induction compared to untreated cells
for duplicate determinations for five different donors. The boxes indicate
the 25th and 75th percentiles. The whiskers above and below the boxes
indicate the highest and lowest values. The medians are marked and
indicated above the boxes. ctrl., control.
TABLE 1—Continued
Category Gene name (UniGene) Designation
Fold regulation ina
TMC724 2151SmT 2151SmO SE01
Adrenomedullin ADM 3.81 3.74 4.78 8.82
Pentaxin-related, rapidly induced by IL-1beta PTX3 12.78 39.59 106.07 120.67
EH domain containing 1 EHD1 3.31 4.27 5.76 6.14
KIAA0854 protein KIAA0854 2.23 2.71 3.22 4.49
Wilms’ tumor 1-associating protein KIAA0105 2.81 3.55 4.45 4.62
Hypothetical protein FLJ20500 2.83 6.62 6.51 5.05
Human DNA sequence from clone RP5-
1174N9 on chromosome 1p34.1–35.3
3.44 3.03 2.93 4.25
a Positive values indicate fold induction, and negative values indicate fold suppression.
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TABLE 2. Individual patterns of differentially expressed macrophage genes in response to two morphotypes of M. avium strain 2151
Morphotype Gene name (UniGene) Designation Foldregulationa
2151SmT Myosin X MYO10 20.82
RAS guanyl releasing protein 1 calcium and DAG regulated RASGRP1 4.47
Neutrophil cytosolic factor 1 NCF1 2.62
DEAD/H Asp-Glu-Ala-Asp/His box polypeptide Y chromosome DBY 2.22
Hypothetical protein HSPC111 2.08
BAI1-associated protein 2 BAIAP2 2.17
Ecotropic viral integration site 2A EVI2A 2.36
Histidyl-tRNA synthetase-like HARSL 2.39
Dual-specificity tyrosine-Y phosphorylation-regulated kinase 2 DYRK2 4.96
i-Beta-1,3-N-acetylglucosaminyltransferase BETA3GNTI 5.76
2151SmO Interleukin 12B/p40 IL12B 47.19
CGI-142 CGI-142 13.51
Mevalonate diphosphodecarboxylase MVD 8.71
Basic leucine zipper transcription factor ATF-like BATF 5.86
RAB33A member RAS oncogene family RAB33A 5.80
Dual-specificity phosphatase 2 DUSP2 4.15
Syntaxin 11 STX11 3.95
Phosphatidic acid phosphatase type 2B PPAP2B 3.40
Ubiquitin-specific protease 12 USP12 3.21
Chemokine (C-C motif) receptor 7 CCR7 3.16
Regulator of G-protein signaling 16 RGS16 2.94
v-rel avian reticuloendotheliosis viral oncogene homolog REL 2.90
Serine or cysteine proteinase inhibitor clade B ovalbumin
member 9
SERPINB9 2.81
CASP8 and FADD-like apoptosis regulator CFLAR 2.70
Musculin-activated B-cell factor-1 MSC 2.66
Translation factor sui1 homolog GC20 2.64
Interferon regulatory factor 1 IRF1 2.63
Chromosome X open reading frame 6 CXORF6 2.55
KIAA0286 protein KIAA0286 2.43
Stannin SNN 2.42
Uridine phosphorylase UP 2.40
Nuclear receptor subfamily 4 group A member 3 NR4A3 2.40
Serine or cysteine proteinase inhibitor clade B ovalbumin
member 8
SERPINB8 2.37
Tight junction protein 2 zona occludens 2 TJP2 2.35
LPS-induced TNF-alpha factor PIG7 2.33
KIAA0084 protein KIAA0084 2.28
Ninjurin 1 NINJ1 2.23
Poliovirus receptor PVR 2.21
SRY sex-determining region Y box 4 SOX4 2.16
v-ets avian erythroblastosis virus E26 oncogene homolog 2 ETS2 2.10
Nucleolar phosphoprotein p130 P130 2.07
Chromosome 21 open reading frame 25 C21ORF25 2.01
Hypothetical protein FLJ13052 FLJ13052 2.04
p8 protein candidate of metastasis 1 P8 2.04
Sialyltransferase 1-beta-galactoside alpha-2,6-sialytransferase SIAT1 2.08
Murine leukemia viral bmi-1 oncogene homolog BMI1 2.10
Zinc finger protein 148 pHZ-52 ZNF148 2.11
Sorting nexin 2 SNX2 2.12
LIM domain only 2 rhombotin-like 1 LMO2 2.13
Adipose differentiation-related protein ADFP 2.14
Coronin actin-binding protein 1A CORO1A 2.16
Interleukin 17 receptor IL17R 2.16
KIAA1224 protein KIAA1224 2.25
ATP-binding cassette subfamily C CFTR/MRP member 5 ABCC5 2.25
Conserved gene amplified in osteosarcoma OS4 2.27
Three prime repair exonuclease 1 DKFZp434J0310 2.33
LCAT-like lysophospholipase LLPL 2.36
KIAA1093 protein KIAA1093 2.37
Proline-serine-threonine phosphatase interacting protein 1 PSTPIP1 2.38
FYN-binding protein FYB-120/130 transcription factor 3 E2A
immunoglobulin enhancer binding factors
FYB 2.39
E12/E47 TCF3 2.42
Regulator of G-protein signaling 2.24kD RGS2 2.44
Protein predicted by clone 23627 HSU79266 2.48
Continued on following page
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nificantly lower extent. Stimulation of human macrophages
with 2151SmO as well as 2151SmT significantly reduced LY64
mRNA expression in all individuals (Fig. 5B), and the inhi-
bition was more pronounced in response to SmO than in
response to SmT (Fig. 5B). Expression of myosin X mRNA
was significantly enhanced in response to 2151SmT and, in
contrast to the microarray results, also after stimulation with
2151SmO (Fig. 5C). Furthermore, 2151SmO consistently in-
duced myosin X mRNA expression to a significantly higher
extent than 2151SmT.
To address this discrepancy between the results from mi-
croarray analysis and RT-PCR, reanalysis of the raw, array-
based gene expression data was performed. Expression of my-
osin X mRNA was induced 33- and 2.8-fold in response to
2151SmT in the two replicate microarray experiments. In re-
sponse to 2151SmO, the induction was 12- and 3.6-fold, but the
difference did not reach statistical significance. Thus, the raw
gene expression values were actually well in accordance with
the RT-PCR data. This is even more remarkable since the
array-based myosin X mRNA expression values were generally
very low (signal, 	50). The fact that changes in gene expres-
sion even at the very low signal end were confirmed by an
independent method again underscores the robustness of our
microarray-based gene expression analysis.
Finally, we scrutinized the macrophage gene expression pro-
files induced by TMC724 and SE01, two genetically completely
unrelated M. avium strains with highly discrepant intracellular
growth properties. The private macrophage expression signa-
ture evoked by TMC724 (compared to all other isolates) con-
tained only two genes, the proto-oncogene c-Myc (twofold
induction) and the vaccinia-related kinase 2 gene (twofold
repression), once more reflecting the overall weak potential of
this M. avium strain to activate macrophages. In contrast, the
individual signature of differentially expressed macrophage
genes in response to SE01 consisted of 87 genes (38 genes
induced, 49 genes suppressed) (Table 3), the highest number
of privately regulated genes in this series.
The SE01-specific induced macrophage transcriptome was
FIG. 5. Expression of IL-12p40, LY64, and myosin X mRNA in human monocyte-derived macrophages after infection with M. avium. Human
MDM were incubated with M. avium isolates 2151SmT and 2151SmO (MOI, 10) for 4 h. Total RNA was isolated, reverse transcribed, and used
for quantitative RT-PCR of IL-12p40 (A), LY64 (B), and myosin X (C) mRNA normalized to beta-2-microglobulin mRNA levels. The values are
the means for duplicate determinations for five different donors. The boxes indicate the 25th and 75th percentiles. The whiskers above and below
the boxes indicate the highest and lowest values. The medians are marked. Significant differences are indicated; an asterisk indicates that the P
value is 	0.05. n.s., not significant; ctrl, control; b2m, beta-2-microglobulin.
TABLE 2—Continued
Morphotype Gene name (UniGene) Designation Foldregulationa
Inositol 1,4,5-trisphosphate 3-kinase B ITPKB 2.56
Glutamate-cysteine ligase catalytic subunit GCLC 2.61
Disabled Drosophila homolog 2 mitogen-responsive
phosphoprotein
DAB2 2.69
Transforming growth factor beta receptor II 70-80kD TGFBR2 2.80
Mad4 homolog myeloid/lymphoid or mixed-lineage leukemia
trithorax Drosophila
MAD4 2.92
Homolog translocated to 2 MLLT2 2.98
Ecotropic viral integration site 2B EVI2B 3.05
Endocrine regulator HRIHFB2436 3.27
Peroxisome proliferative activated receptor gamma PPARG 3.63
Interferon gamma-inducible protein 16 IFI16 3.64
Protein tyrosine phosphatase nonreceptor type 22 lymphoid PTPN22 3.72
B cell linker protein SLP65 4.70
KIAA0500 protein KIAA0500 4.94
KIAA0846 protein KIAA0846 6.28
Lymphocyte antigen 64 mouse homolog radioprotective 105kD LY64/CD180 23.10
a Positive values indicate fold induction, and negative values indicate fold suppression.
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remarkable in that a number of genes involved in the down-
regulation of a proinflammatory immune response were highly
upregulated. Thus, profound upregulation (15-fold) of suppres-
sor of cytokine signaling 1 (SOCS-1/SSI-1), a negative regulator
of gamma interferon (IFN-) signaling (38), was accompanied by
repression of IFN- receptor 1 (twofold). In addition, the anti-
inflammatory cytokine IL-10 was significantly induced (sixfold)
only by SE01 (Table 3).
DISCUSSION
This study shows that the extent of early macrophage sig-
naling events induced by individual strains of M. avium is
directly correlated with the quantity of genes and the overall
magnitude of gene regulation elicited by each individual strain.
While this type of classification of M. avium strains proved to
be robust, in that three different methods of evaluation (MAP
TABLE 3. Individual pattern of differentially expressed macrophage genes in response to M. avium strain SE01
Gene name (UniGene) Designation Foldregulationa
JAK binding protein SSI-1 15.77
Plasminogen activator, tissue PLAT 10.26
Hairy (Drosophila) homolog HRY 8.51
Platelet-derived growth factor beta polypeptide PDGFB 7.96
Solute carrier family 1, glial high-affinity glutamate transport, membrane 2 SLC1A2 7.33
BCL2-like 1 BCL2L1 7.18
Signaling lymphocytic activation molecule SLAM 6.92
Colony-stimulating factor 3 (granulocyte) CSF3 6.69
Colony-stimulating factor 2 (granulocyte-macrophage) CSF2 6.66
Interleukin 10 IL10 5.95
Dual-specificity phosphatase 8 DUSP8 5.58
Aldehyde dehydrogenase 5 ALDH5 4.65
Dual-specificity tyrosine-phosphorylation-regulated kinase 3 DYRK3 3.56
v-src avian sarcoma (Schmidt-Ruppin A-2) SRC 3.49
Homo sapiens C2H2-type zinc finger protein mRNA, complete cds 3.37
Thymopoietin TMPO 3.33
CD83 antigen CD83 3.31
Growth arrest and DNA damage-inducible, alpha GADD45A 3.21
Coagulation factor III (thromboplastin, tissue factor) F3 3.20
EST, moderately similar to POL2 human retrovirus-related POL polyprotein 2.90
Dishevelled 3 (homologous to Drosophila dsh) DVL3 2.78
NCK adaptor protein 2 NCK2 2.69
Cytokine-inducible kinase CNK 2.69
Acetyl LDL receptor; SREC SREC 2.69
Mitogen-activated protein kinase-activated protein kinase 2 MAPKAPK2 2.67
Prostaglandin I2 (prostacyclin) receptor (IP) PTGIR 2.60
Dual-specificity phosphatase 1 DUSP1 2.60
Glycophorin C (Gerbich blood group) GYPC 2.60
Creatine kinase, brain CKB 2.53
Glutaredoxin (thioltransferase) GLRX 2.38
X-box binding protein 1 XBP1 2.36
Prostaglandin E receptor 4 (subtype EP4) PTGER4 2.31
Signal transducer and activator of transcription 5A STAT5A 2.28
Pleiomorphic adenoma gene-like 2 PLAGL2 2.24
CCAAT/enhancer binding protein (C/EBP), delta CEBPD 2.20
Guanylate binding protein 2, interferon inducible GBP2 2.18
BTG family, member 3 BTG3 2.13
ras homolog gene family, member G (rho G) ARHG 2.09
KIAA0759 protein KIAA0759 2.07
cAMP-responsive element modulator CREM 2.09
Diacylglycerol kinase, zeta (104kD) DGKZ 2.11
Myeloid cell nuclear differentiation antigen MNDA 2.12
Homo sapiens cDNA: FLJ21449 fis, clone COL04483, highly similar to
AF010235 H. sapiens mRNA from chromosome 5q31-33 region
2.15
Putative human HLA class II associated protein I PHAP1 2.17
Interferon gamma receptor 1 IFNGR1 2.19
Src-like-adapter SLA 2.19
RAS p21 protein activator (GTPase activating protein) 1 RASA1 2.20
Homo sapiens mRNA; cDNA (from clone DKFZp564N1272); complete cds 2.22
DKFZP566O1646 protein 2.24
Proliferating cell nuclear antigen PCNA 2.26
KIAA0229 protein KIAA0229 2.28
Nucleoporin 214kD (CAIN) NUP214 2.30
Human clone 23801 mRNA sequence 2.30
MKP-1 like protein tyrosine phosphatase MKP-L 2.31
Speckle-type POZ protein SPOP 2.33
a Positive values indicate fold induction, and negative values indicate fold suppression.
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kinase phosphorylation, TNF- secretion, and size of infec-
tion-induced transcriptome) showed consistent results with
four different isolates, we found no straightforward association
of a specific macrophage response signature with the pathoge-
nicities of the infecting strains, as measured by their intracel-
lular replication rates in vitro. Therefore, the virulence of the
species M. avium is not mirrored by a stereotypic, species-
specific macrophage response, as previously suggested (28).
Nor is virulence of M. avium invariably a unique failure to
activate macrophages, as hypothesized previously (24, 49).
Rather, our data imply that virulence must be explained at the
level of the individual isolate of M. avium; while some isolates
may modulate host defenses by manipulating specific host de-
fense genes (such as the gene encoding IL-12p40, LY64,
SOCS-1, or IL-10, as identified in this study), other isolates
may simply rely on their intrinsic resistance to antimycobacte-
rial effector mechanisms.
Our data corroborate previous findings from microarray
analyses performed with macrophages infected with mycobac-
teria or stimulated with mycobacterial components (10, 14, 42).
In particular, they support the concept that following interac-
tion with mycobacteria, a prewired infection-related gene ex-
pression program is induced in macrophages, consisting of
signaling components, transcriptional machinery, and media-
tors and receptors necessary to enhance myelomonocytic cell
recruitment and activation. This program differs from that
elicited by protozoan or helminth parasites in that, for exam-
ple, many more interferon-inducible genes are triggered (14).
A previous study detailing the expression signature of mac-
rophages in response to M. avium described the upregulation
of approximately 150 genes involved in signal transduction,
transcription, adhesion, apoptosis, protein turnover, homeo-
stasis, detoxification, and general metabolism or coding for
receptor-associated proteins, cytokines, and chemokines (28).
While many of the genes described in that report are also listed
in our M. avium-induced common signature (28) (Table 1),
there are individual differences in both the number and the
type of genes that were found to be regulated. These differ-
ences are most likely due to donor variability and different
times of analysis, but they probably also reflect the use of yet
another M. avium strain in that study (only described as a
smooth transparent isolate). The fact that IL-12p40 and IL-10
were not appreciably induced but that a number of ras-associ-
ated signaling molecules were expressly regulated by that strain
put it in a category not dissimilar to that shown here for
2151SmT (28).
The results of this study and a recent study (9) provide
evidence that within minutes following exposure, the macro-
phage responses to M. avium strains already differ at the level
of signal transduction. Virulent or persistent strains, such as M.
avium 2151SmT or TMC724, induce much less phosphoryla-
tion of MAP kinases than avirulent isolates, such as 2151SmO,
induce. Virulence may therefore be an intrinsic inability of
certain isolates to activate macrophages (e.g., due to a lack of
stimulating cell wall-associated structures). TMC724 and both
morphotypes of strain 2151 contain the ser2 gene cluster, which
is involved in glycosylation of glycopeptidolipids of the cell
wall. Genetic characterization of this region revealed strain-
specific variations in this region, indicating structural differ-
ences in the individual cell wall composition (7, 20). The quan-
tity of receptor-ligating structures in individual strains of M.
avium has, however, not been accurately determined thus far.
Alternatively, virulence may be the consequence of active
suppression of early signaling events within the host cell (e.g.,
by activating phosphatases) (37). In this respect, it is notewor-
thy that the virulent SE01 strain significantly induced two dual-
specificity phosphatases (phosphatases 1 and 8).
Highly stringent statistical evaluation of the microarray data
initially showed strain-specific transcriptional activation of sev-
eral macrophage genes, e.g., the genes encoding IL-12p40,
LY64, and myosin X. Independent confirmation of the expres-
sion levels of these genes by quantitative RT-PCR revealed
that rather than representing “exclusively” regulated genes, the
genes were regulated in a more pronounced fashion by infec-
tion with 2151SmO than by infection with 2151SmT. Further
analysis of this discrepancy showed that in the microarray-
based screening these genes did in fact also show regulation
following infection with other strains but that the magnitude
was not sufficient to meet our statistical criteria.
The control of mycobacterial infections is known to depend
on IL-12, which is essential for inducing an appropriate IFN-
response (2, 17, 39). Impaired and/or delayed expression of
IL-12 may therefore be interpreted as a corollary of virulence
in individual M. avium strains (such as 2151SmT or TMC724).
Conversely, the high induction of IL-12 formation by the avir-
ulent 2151SmO strain may be termed suicidal. However, it
should be mentioned that the biology of the heterodimeric
IL-12 family of cytokines is more complex and that excess
IL-12p40 dimers can also antagonize IL-12p70 functions at the
IL-12 receptor (12, 30).
The individual response to M. avium 2151SmO indicated
profound downregulation of LY64 (CD180, RP105), a mem-
ber of the Toll-like receptor (TLR) family, which mediates the
LPS response in B lymphocytes (reviewed in reference 35).
LY64 has previously been found to be differentially expressed
in tumor-associated macrophages (26) but has not been linked
to mycobacterial infections thus far. Interestingly, LY64 has
functional similarities with TLR4. While there is a report that
TLR4-defective mice are as susceptible to infection with M.
avium as with wild-type controls, the role of TLR4 in the
control of mycobacterial infections is controversial (1, 23, 47,
50). Elucidating the role of LY64 in M. avium pathogenesis
might shed new light on the contribution of different members
of the TLR family in the innate response against mycobacterial
infection.
Collectively, our data show that for some strains, such as
2151SmT and 2151SmO, the overall magnitude of host cell
activation, as determined by MAP kinase phosphorylation,
TNF- production, and the size of the induced transcriptome,
is inversely correlated with the capacity to persist and grow
inside macrophages. While there is no specific “virulence-as-
sociated” signature of the virulent 2151SmT strain, the strong
regulation of some genes, such as the IL-12p40, myosin X, and
LY64 genes, by 2151SmO may be a good corollary of this
strain’s lack of virulence. For TMC724, there is also no “per-
sistence-associated,” strain-specific macrophage gene expres-
sion signature. In fact, TMC724 induces only very little gene
regulation, and therefore activation, in human host cells. This
may reflect its avian origin, which endowed it with a height-
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ened imperviousness to constitutively expressed effector mol-
ecules in human macrophages.
The macrophage transcriptome induced by M. avium SE01 is
particularly enlightening, as it shows that the analysis of a
strain-specific signature may help us understand this isolate’s
behavior inside the macrophage. Obviously, despite very strong
activation of the innate immune response, this strain is able to
persist in macrophages. Here, SE01 induces upregulation of
SOCS-1/SSI-1, a negative feedback regulator of signaling
events via janus kinases induced by cytokines (38). SOCS-1-
mediated negative regulation of IFN--induced signals can be
hypothesized as one mechanism by which SE01 promotes its
survival inside macrophages. Moreover, infection with SE01
induces the transcriptional downregulation of IFN- receptor
1, again indicating effective counteraction of IFN--mediated
eradication (16, 18, 32). In addition, SE01 was the only strain
found to induce very high IL-10 gene transcription, which may
interfere with antimycobacterial effector mechanisms (45, 55).
If the results are taken together, SE01 seems to be capable of
tipping the scale of macrophage activation toward a net “anti-
inflammatory” score which favors persistence.
In conclusion, microarray analyses of gene expression pat-
terns of human macrophages in response to M. avium strains
with different levels of virulence yielded a number of genes
associated with a common antimicrobial macrophage re-
sponse, consistent with previous reports. Overall, quantitative
rather than qualitative differences of gene regulation were
associated with the capacity of M. avium strains to grow inside
macrophages. In particular, our data provide no evidence that
the virulence and pathogenicity of M. avium as a species can be
unequivocally deduced from the macrophage gene response
signatures that individual isolates elicit. Instead, there are at
least three distinct explanations for virulence at the level of the
individual strain. First, isolates such as 2151SmT or TMC724
elicit only a low or delayed type of host response, which contrib-
utes to their escaping antimycobacterial effector mechanisms.
Second, isolates such as SE01 induce a strong macrophage
response in which the net balance of pro- and anti-inflamma-
tory activities appears to be skewed towards suppressing anti-
mycobacterial protection. Third, isolates such as TMC724 may
be largely impervious to antimycobacterial effector molecules
in human macrophages irrespective of the host response that
they elicit.
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